| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Health Sciences | 127 | 3.8K | 199.6K |
2 | Engineering | 81 | 954 | 60.5K |
3 | Education | 63 | 618 | 32K |
4 | Arts | 32 | 140 | 6.3K |
5 | Business | 17 | 35 | 1.3K |
University of Kansas Medical Center
×
41.3K
Publications
3.2M
Citations
| Year | Citations | |
|---|---|---|
2017 | 6.5K | |
2017 | 5.3K | |
2021 | 4.5K | |
2017 | 3.7K | |
1992 | 3.4K | |
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study Barbara Burtness, Kevin J. Harrington, Richard Greil, Neoadjuvant TherapyChemotherapy Versus CetuximabMedicinePathologyHead And Neck Cancer | 2019 | 3K |
2003 | 2.9K | |
2000 | 2.9K | |
2021 | 2.5K | |
2021 | 2.5K |
Page 1
Page 1